Hepatic

Records whose assigned subject headings cover the liver, hepatic steatosis, fibrosis or the transaminases indexed with them. 9 of the 186 records indexed across this publication's scope carry at least one of them, covering 9 of the 17 compounds.

Assignment is mechanical. A record sits under this endpoint because the indexer attached one of the subject headings listed further down, not because anyone read it. The cell counts records. It does not report a result, a direction or a magnitude, and nothing in the corpus would let it.

Record coverage by compound and record class

Column keys: Ph 3 phase 3; Ph 2 phase 2; Ph 1 phase 1; Trial, no phase trial, no phase assigned; Review review or synthesis; Other not a registered trial record. Phase is read from the publication type the indexer assigned to each record, never from its title.

A zero cell records that no indexed record for that compound carries one of these subject headings. It is the absence of a retrieved report, never the absence of the thing itself. The full record set for each compound is held on its own trial page.

Subject headings that place a record here

The full set is fixed and printed here so the assignment can be checked by hand against the method. 8 of the 8 headings in the set occur on at least one record in scope.

The records

9 distinct records, newest first within each class. A record indexed under more than one compound is listed once and named under each.

What this page does not say

• It does not say what any record found. Subject headings describe what a record is about, not what it concluded.
• It does not rank the compounds. The column order is fixed by record class and the row order is alphabetical, neither of which carries a judgement.
• It does not represent the literature. The counts are of records this corpus carries; the queries behind them returned 48,938 records in total across the compounds in scope.
• It is not clinical guidance, and it is not reviewed by a clinician. The disclaimer states the limits in full.